374 related articles for article (PubMed ID: 31499490)
1. Outcomes after Application of Active Bone Conducting Implants.
Koro E; Werner M
Audiol Neurootol; 2019; 24(4):197-205. PubMed ID: 31499490
[TBL] [Abstract][Full Text] [Related]
2. Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant.
Sprinzl G; Toner J; Koitschev A; Berger N; Keintzel T; Rasse T; Baumgartner WD; Honeder C; Magele A; Plontke S; Götze G; Schmutzhard J; Zelger P; Corkill S; Lenarz T; Salcher R
Eur Arch Otorhinolaryngol; 2023 Apr; 280(4):1565-1579. PubMed ID: 36625869
[TBL] [Abstract][Full Text] [Related]
3. Preliminary functional results and quality of life after implantation of a new bone conduction hearing device in patients with conductive and mixed hearing loss.
Ihler F; Volbers L; Blum J; Matthias C; Canis M
Otol Neurotol; 2014 Feb; 35(2):211-5. PubMed ID: 24448279
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Follow-Up in Active Transcutaneous Bone Conduction Implants.
Koro E; Lundgren E; Smeds H; Werner M
Otol Neurotol; 2024 Jan; 45(1):58-64. PubMed ID: 38085764
[TBL] [Abstract][Full Text] [Related]
5. Audiological and clinical outcomes of a transcutaneous bone conduction hearing implant: Six-month results from a multicentre study.
den Besten CA; Monksfield P; Bosman A; Skarzynski PH; Green K; Runge C; Wigren S; Blechert JI; Flynn MC; Mylanus EAM; Hol MKS
Clin Otolaryngol; 2019 Mar; 44(2):144-157. PubMed ID: 30358920
[TBL] [Abstract][Full Text] [Related]
6. Prediction of postoperative speech comprehension with the transcutaneous partially implantable bone conduction hearing system Osia®.
Arndt S; Wesarg T; Aschendorff A; Speck I; Hocke T; Jakob TF; Rauch AK
HNO; 2024 Jan; 72(Suppl 1):1-9. PubMed ID: 37812258
[TBL] [Abstract][Full Text] [Related]
7. Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(1):1-165. PubMed ID: 32194878
[TBL] [Abstract][Full Text] [Related]
8. Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia®.
Rauch AK; Wesarg T; Aschendorff A; Speck I; Arndt S
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4279-4288. PubMed ID: 34792628
[TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of the Bonebridge transcutaneous active direct-drive bone-conduction hearing implant at 1-year device use.
Schmerber S; Deguine O; Marx M; Van de Heyning P; Sterkers O; Mosnier I; Garin P; Godey B; Vincent C; Venail F; Mondain M; Deveze A; Lavieille JP; Karkas A
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1835-1851. PubMed ID: 27475796
[TBL] [Abstract][Full Text] [Related]
10. Long-term audiological benefit with an active transcutaneous bone-conduction device: a retrospective cohort analysis.
Hundertpfund J; Meyer JE; Ovari A
Eur Arch Otorhinolaryngol; 2022 Jul; 279(7):3309-3326. PubMed ID: 34424382
[TBL] [Abstract][Full Text] [Related]
11. Clinical performance, audiological outcomes, and quality of life of the Cochlear Osia ® system.
Young A; Fechtner L; Brennan C; Rende S; Wazen J
Am J Otolaryngol; 2023; 44(5):103951. PubMed ID: 37329694
[TBL] [Abstract][Full Text] [Related]
12. A New Active Osseointegrated Implant System in Patients with Single-Sided Deafness.
Willenborg K; Avallone E; Maier H; Lenarz T; Busch S
Audiol Neurootol; 2022; 27(1):83-92. PubMed ID: 33902037
[TBL] [Abstract][Full Text] [Related]
13. The Sophono bone-conduction system: Surgical, audiologic, and quality-of-life outcomes.
Mclean T; Pai I; Philipatos A; Gordon M
Ear Nose Throat J; 2017 Jul; 96(7):E28-E33. PubMed ID: 28719716
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of audiological outcomes and compliance between the Osia system and other bone conduction hearing implants.
Kim Y; Choe G; Oh H; Choi BY
Eur Arch Otorhinolaryngol; 2023 May; 280(5):2217-2224. PubMed ID: 36318324
[TBL] [Abstract][Full Text] [Related]
15. Objective and subjective results of the Bonebridge transcutaneous active direct-drive bone conduction hearing implant.
Alzhrani F
Saudi Med J; 2019 Aug; 40(8):797-801. PubMed ID: 31423516
[TBL] [Abstract][Full Text] [Related]
16. Outcome prediction for Bonebridge candidates based on audiological indication criteria.
Wimmer W; von Werdt M; Mantokoudis G; Anschuetz L; Kompis M; Caversaccio M
Auris Nasus Larynx; 2019 Oct; 46(5):681-686. PubMed ID: 30635142
[TBL] [Abstract][Full Text] [Related]
17. The bone conduction implant: Clinical results of the first six patients.
Reinfeldt S; Håkansson B; Taghavi H; Fredén Jansson KJ; Eeg-Olofsson M
Int J Audiol; 2015 Jun; 54(6):408-16. PubMed ID: 25705995
[TBL] [Abstract][Full Text] [Related]
18. A comparative study on speech in noise understanding with a direct acoustic cochlear implant in subjects with severe to profound mixed hearing loss.
Lenarz T; Verhaert N; Desloovere C; Desmet J; D'hondt C; González JC; Kludt E; Macías AR; Skarżyński H; Van de Heyning P; Vyncke C; Wasowski A
Audiol Neurootol; 2014; 19(3):164-74. PubMed ID: 24556905
[TBL] [Abstract][Full Text] [Related]
19. Audiologic and surgical outcomes of a novel, nonpercutaneous, bone conducting hearing implant.
Sylvester DC; Gardner R; Reilly PG; Rankin K; Raine CH
Otol Neurotol; 2013 Jul; 34(5):922-6. PubMed ID: 23370564
[TBL] [Abstract][Full Text] [Related]
20. Three-Year Follow-Up with the Bone Conduction Implant.
Persson AC; Reinfeldt S; Håkansson B; Rigato C; Fredén Jansson KJ; Eeg-Olofsson M
Audiol Neurootol; 2020; 25(5):263-275. PubMed ID: 32268333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
